Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: VENATORX PHARMACEUTICALS INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2013-09-16 to 2019-09-30
Current total value of award: $28199895.53
Description: DEVELOPMENT OF THERAPEUTIC MEDICAL COUNTERMEASURES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES